Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ryan J. Watts currently holds 2,120,384 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan J. Watts has been a net seller of DNLI stock. They have purchased $0 and sold $38.7M worth of shares.
Ryan J. Watts's most recent insider trade was on Aug 12, 2026, when they sold 32,220 shares at $0.00 per share.
Ryan J. Watts serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 146 insider transactions totaling $38.7M over their tenure at the company.
Ryan J. Watts holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Ryan J. Watts has shown a selling trading pattern, with $0 in total purchases and $38.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ryan J. Watts was on Jul 9, 2025, when they sold $7.4M worth of DNLI shares. This transaction involved 495,282 shares at $15.00 per share.
Ryan J. Watts currently owns 2,120,384 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ryan J. Watts's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ryan J. Watts has 146 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Ryan J. Watts and 40,000+ other insiders.